TABLE 3

Comparison of CBF, V0, and Other Parametric Values (Mean ± SD) in the 2 Patient Groups

ParameterGroup A (n = 8)Group B (n = 8)
IpsilateralContralateralIpsilateralContralateral
CBF (mL/min/100 g)
 Baseline36.4 ± 10.9*43.0 ± 8.735.9 ± 4.740.5 ± 6.7
 ACZ34.9 ± 11.1*55.0 ± 8.946.9 ± 4.9*,56.2 ± 8.5
 % Change−4.1 ± 12.0*29.9 ± 18.332.2 ± 8.239.6 ± 12.7
V0 (mL/100 g)
 Baseline1.56 ± 0.421.85 ± 0.461.70 ± 0.53*2.04 ± 0.40
 ACZ1.90 ± 0.41,§2.90 ± 0.972.40 ± 0.70*,3.12 ± 0.45
 % Change25.0 ± 25.3*55.6 ± 30.244.0 ± 24.255.8 ± 22.1
CMRo2 (mL/min/100 g)2.70 ± 0.482.92 ± 0.322.82 ± 0.29*3.15 ± 0.39
OEF (%)51.3 ± 7.5*46.7 ± 6.248.5 ± 4.947.7 ± 5.8
CBV (mL/100 g)4.65 ± 0.314.17 ± 0.574.09 ± 0.293.88 ± 0.32
  • * P < 0.01 comparing right and left hemispheres (repeated-measures ANOVA with paired t test).

  • P < 0.05 comparing right and left hemispheres (repeated-measures ANOVA with paired t test).

  • P < 0.005 comparing the 2 conditions of baseline and ACZ injection (repeated-measures ANOVA with paired t test).

  • § P < 0.05 comparing the 2 conditions of baseline and ACZ injection (repeated-measures ANOVA with paired t test).